Osiris Therapeutics, Inc., a pioneering leader in regenerative medicine, is headquartered in the United States. Founded in 1992, the company has made significant strides in the development of innovative cellular therapies, particularly in the fields of orthopaedics, wound care, and inflammatory diseases. Osiris is renowned for its unique core products, including the groundbreaking Grafix® and Ovation® lines, which utilise advanced stem cell technology to promote healing and tissue regeneration. These products stand out in the market due to their ability to enhance recovery while minimising complications. With a strong market position, Osiris Therapeutics has achieved notable milestones, including regulatory approvals and partnerships that underscore its commitment to advancing healthcare solutions. The company continues to be at the forefront of the regenerative medicine industry, driving research and development to improve patient outcomes.
We don't have data for Osiris Therapeutics, Inc., but we can show you information about their parent organization instead.
View parent company